Evaluation of Deep Learning Algorithms to Predict Multiple Dementia-Related Neuropathologies from Brain MRI, Clinical and Genetic Data
Authors:
- Tamoghna ChattopadhyayTCTamoghna Chattopadhyay
- Rudransh KushRKRudransh Kush
- Pavithra SenthilkumarPSPavithra Senthilkumar
- Christopher PattersonCPChristopher Patterson
- Conor Owens-WaltonCOConor Owens-Walton
- Emma J. GleaveEGEmma J. Gleave
- Sophia I. ThomopoulosSTSophia I. Thomopoulos
- Sterling C. JohnsonSJSterling C. Johnson
- Elizabeth C. MorminoEMElizabeth C. Mormino
- Timothy J. HohmanTHTimothy J. Hohman
- Paul M. ThompsonPTPaul M. Thompson
Preprint
Abstract
Alzheimer’s disease and related dementias (ADRD) involve overlapping neurodegenerative and vascular pathologies—such as amyloid-β (Aβ), tau, cerebral amyloid angiopathy (CAA), TDP-43, and alpha-synuclein—that complicate diagnosis and treatment. While PET and CSF biomarkers are useful for detecting Aβ and tau, they are invasive, expensive, and not widely available. In contrast, magnetic resonance imaging (MRI) is non-invasive and widely accessible, offering an opportunity for pathology prediction when combined with deep learning. Most prior studies have focused on single-pathology detection, but there remains a need for models that can jointly predict multiple co-occurring pathologies. In this work, we evaluate deep learning models that integrate structural MRI with demographic, clinical, and genetic data to classify six autopsy-confirmed neuropathologies: Aβ, tau, CAA, TDP-43, hippocampal sclerosis, and dementia with Lewy bodies. We compare our hybrid deep learning model to AutoGluon, an automated machine learning framework. Our findings support the potential of multimodal AI to enable non-invasive, comprehensive neuropathological profiling in ADRD.Keywords
Funding Information
- NIH NIA (U01 AG068057)
- NIH NIA (U01AG082350)
- NIH NIA (U24AG074855)
This publication has 20 references indexed in Scilit:
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Automated detection of Alzheimer’s disease: a multi-modal approach with 3D MRI and amyloid PETScientific Reports, 2024
- The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studiesExperimental & Molecular Medicine, 2020
- Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathologyScientific Reports, 2020
- The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal casesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- TDP-43 Pathology, Cognitive Decline, and Dementia in Old AgeJAMA Neurology, 2013
- Pathologic Lesions in Neurodegenerative Diseases2012
- REVIEW: tau protein pathology in Alzheimer’s disease and related disordersNeuropathology and Applied Neurobiology, 1999
- Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubulesNature Medicine, 1996